SAN FRANCISCO, Jan. 8, 2021 /PRNewswire/ -- Nearly all cancer patients face fear, anxiety, and uncertainty following diagnosis and treatment. Cancer-related distress can impact a patient's emotional and physical well-being, which for many has been further compounded by the COVID-19 pandemic. Founded by a team of biotech veterans, Blue Note Therapeutics, Inc., is leveraging deep scientific and clinical expertise, neuroscience, and digital innovation to make mental health care available to any cancer patient at any time. In 2020, the company launched
COVID Cancer Care, a digital program intended to help adults with cancer cope with stress and anxiety related to the COVID-19 pandemic.